RDFA
Ritter Daniher Financial Advisory’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63
| Closed | -$1.05K | – | 337 |
|
|
2025
Q1 | $1.05K | Hold |
63
| – | – | ﹤0.01% | 294 |
|
|
2024
Q4 | $1.16K | Hold |
63
| – | – | ﹤0.01% | 292 |
|
|
2024
Q3 | $969 | Hold |
63
| – | – | ﹤0.01% | 298 |
|
|
2024
Q2 | $1.02K | Hold |
63
| – | – | ﹤0.01% | 290 |
|
|
2024
Q1 | $1.17K | Hold |
63
| – | – | ﹤0.01% | 283 |
|
|
2023
Q4 | $1.97K | Hold |
63
| – | – | ﹤0.01% | 310 |
|
|
2023
Q3 | $1.31K | Hold |
63
| – | – | ﹤0.01% | 321 |
|
|
2023
Q2 | $1.51K | Hold |
63
| – | – | ﹤0.01% | 293 |
|
|
2023
Q1 | $1.19K | Hold |
63
| – | – | ﹤0.01% | 271 |
|
|
2022
Q4 | $1K | Hold |
63
| – | – | ﹤0.01% | 263 |
|
|
2022
Q3 | $1K | Hold |
63
| – | – | ﹤0.01% | 230 |
|
|
2022
Q2 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 229 |
|